| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |